SARS-CoV-2 Recombinant DNA vaccine (BioNet-Asia)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameSARS-CoV-2 Recombinant DNA vaccine (BioNet-Asia)
Drug Alias NameCOVIGEN
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBionet-Asia Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionet-Asia Co LtdUniversity of Sydney
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A